HIF-1α depletion results in SP1-mediated cell cycle disruption and alters the cellular response to chemotherapeutic drugs

Cell Cycle

Volumn 10, Issue 8, 2011, Pages 1249-1260

  Culver, Carolyn ^a   Melvin, Andrew ^a   Mudie, Sharon ^a   Rocha, Sonia ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Cell cycle; HIF 1; p21; p27; SP1

Indexed keywords

ANTIINFECTIVE AGENT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROTEIN P21; PROTEIN P27; SHORT HAIRPIN RNA;

ARTICLE; CELL ACTIVATION; CELL CYCLE; CELL CYCLE G1 PHASE; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROTEIN DEPLETION;

EID: 79954550386     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.8.15326     Document Type: Article

References (61)

1. Rankin EB, Giaccia AJ. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 2008; 15:678.
2. Yang QC, Zeng BF, Dong Y, Shi ZM, Jiang ZM, Huang J. Overexpression of hypoxia-inducible factor- 1alpha in human osteosarcoma: correlation with clinicopathological parameters and survival outcome. Jpn J Clin Oncol 2007; 37:127-34. (Pubitemid 47090710)
3. Yoshimura H, Dhar DK, Kohno H, Kubota H, Fujii T, Ueda S, et al. Prognostic Impact of Hypoxia-Inducible Factors 1α and 2α in Colorectal Cancer Patients. Clinical Cancer Research 2004; 10:8554-60. (Pubitemid 40053424)
4. Shibaji T, Nagao M, Ikeda N, Kanehiro H, Hisanaga M, Ko S, et al. Prognostic significance of HIF-1alpha overexpression in human pancreatic cancer. Anticancer Res 2003; 23:4721-7. (Pubitemid 38173890)
5. Schindl M, Schoppmann SF, Samonigg H, Hausmaninger H, Kwasny W, Gnant M, et al. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res 2002; 8:1831-7. (Pubitemid 34633742)
6. Osada R, Horiuchi A, Kikuchi N, Yoshida J, Hayashi A, Ota M, et al. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma. Hum Pathol 2007; 38:1310-20. (Pubitemid 47247486)
7. Winter SC, Shah KA, Han C, Campo L, Turley H, Leek R, et al. The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer. Cancer 2006; 107:757-66. (Pubitemid 44232668)
8. WAF1/CIP1 expression to cell apoptosis and clinical outcome in patients with gastric cancer. World J Surg Oncol 2006; 4:94.
9. Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 2000; 60:4693-6.
10. Theodoropoulos VE, Lazaris A, Sofras F, Gerzelis I, Tsoukala V, Ghikonti I, et al. Hypoxia-inducible factor 1alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer. Eur Urol 2004; 46:200-8. (Pubitemid 38902737)
11. Aebersold DM, Burri P, Beer KT, Laissue J, Djonov V, Greiner RH, Semenza GL. Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 2001; 61:2911-6. (Pubitemid 32691934)
12. Unruh A, Ressel A, Mohamed HG, Johnson RS, Nadrowitz R, Richter E, et al. The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy. Oncogene 2003; 22:3213-20. (Pubitemid 36712933)
13. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399:271-5. (Pubitemid 29246458)
14. Iliopoulos O, Levy AP, Jiang C, Kaelin WG Jr, Goldberg MA. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci USA 1996; 93:10595-9. (Pubitemid 26333032)
15. Jiang BH, Jiang G, Zheng JZ, Lu Z, Hunter T, Vogt PK. Phosphatidylinositol-3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ 2001; 12:363-9. (Pubitemid 32685637)
16. Fandrey J, Gorr TA, Gassmann M. Regulating cellular oxygen sensing by hydroxylation. Cardiovasc Res 2006; 71:642-51. (Pubitemid 44848002)
17. Kaelin WG Jr, Ratcliffe PJ. Oxygen sensing by meta-zoans: the central role of the HIF hydroxylase pathway. Mol Cell 2008; 30:393-402. (Pubitemid 351681994)
18. Gorlach A, Bonello S. The cross-talk between NFkappaB and HIF-1: further evidence for a significant liaison. Biochem J 2008; 412:17-9.
19. van Uden P, Kenneth NS, Rocha S. Regulation of hypoxia-inducible factor-1alpha by NFkappaB. Biochem J 2008; 412:477-84.
20. Bonello S, Zahringer C, BelAiba RS, Djordjevic T, Hess J, Michiels C, et al. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler Thromb Vasc Biol 2007; 27:755-61. (Pubitemid 46606703)
21. Deudero JJ, Caramelo C, Castellanos MC, Neria F, Fernandez-Sanchez R, Calabia O, et al. Induction of hypoxia-inducible factor 1alpha gene expression by vascular endothelial growth factor. J Biol Chem 2008; 283:11435-44.
22. Zelzer E, Levy Y, Kahana C, Shilo BZ, Rubinstein M, Cohen B. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ ARNT. EMBO J 1998; 17:5085-94. (Pubitemid 28408474)
23. Feldser D, Agani F, Iyer NV, Pak B, Ferreira G, Semenza GL. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res 1999; 59:3915-8. (Pubitemid 29393552)
24. Hellwig-Burgel T, Rutkowski K, Metzen E, Fandrey J, Jelkmann W. Interleukin-1beta and tumor necrosis factor- alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 1999; 94:1561-7. (Pubitemid 29411306)
25. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol-3-kinase/PTEN/ AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 2000; 60:1541-5. (Pubitemid 30183422)
26. Gorlach A, Diebold I, Schini-Kerth VB, Berchner- Pfannschmidt U, Roth U, Brandes RP, et al. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase. Circ Res 2001; 89:47-54. (Pubitemid 34135491)
27. Spinella F, Rosano L, Di Castro V, Natali PG, Bagnato A. Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1alpha in ovarian carcinoma cells. J Biol Chem 2002; 277:27850-5. (Pubitemid 34966730)
28. Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL. HER2 (neu) signaling increases the rate of hypoxia- inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 2001; 21:3995-4004.
29. Bardos JI, Chau NM, Ashcroft M. Growth factor-mediated induction of HDM2 positively regulates hypoxia-inducible factor 1alpha expression. Mol Cell Biol 2004; 24:2905-14. (Pubitemid 38381279)
30. Berra E, Benizri E, Ginouves A, Volmat V, Roux D, Pouyssegur J. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. EMBO J 2003; 22:4082-90. (Pubitemid 37021737)
31. Blundell RA. The Biology of p21 - Review Paper. American Journal of Biochemistry and Biotechnology 2006; 2:33-40.
32. Morris MR, Hughes DJ, Tian YM, Ricketts CJ, Lau KW, Gentle D, et al. Mutation Analysis of Hypoxia-inducible Factors HIF1A and HIF2A in Renal Cell Carcinoma. Anticancer Research 2009; 29:4337-43.
33. Waf1/Cip1 expression. Oncogene 1998; 17:1691-703.
34. Dotto GP. p21(WAF1/Cip1): more than a break to the cell cycle? Biochim Biophys Acta 2000; 1471:43-56.
35. WAF1/CIP1 in apoptosis and autophagy. J Biol Chem 2008; 283:388-97.
36. Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002; 1:639-49.
37. 1 cyclin-dependent kinases. Cell 1993; 75:805-16.
38. 1 cyclin-dependent kinases. Genes Dev 1995; 9:1149-63.
39. WAF1, pRB and p53 is dependent on the integrity of the endogenous cell cycle control pathways in human glioblastoma cell lines. Exp Cell Res 1998; 238:51-62.
40. Murakami H, Nurse P. DNA replication and damage checkpoints and meiotic cell cycle controls in the fission and budding yeasts. Biochem J 2000; 349:1-12. (Pubitemid 30440158)
41. Kennett SB, Udvadia AJ, Horowitz JM. Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription. Nucleic Acids Res 1997; 25:3110-7. (Pubitemid 27331406)
42. Lee SJ, Ha MJ, Lee J, Nguyen P, Choi YH, Pirnia F, et al. Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells. J Biol Chem 1998; 273:10618-23. (Pubitemid 28227674)
43. WAF1/CiP1. Nature 1997; 389:187-90.
44. Li JM, Datto MB, Shen X, Hu PP, Yu Y, Wang XF. Sp1, but not Sp3, functions to mediate promoter activation by TGFbeta through canonical Sp1 binding sites. Nucleic Acids Res 1998; 26:2449-56. (Pubitemid 28297348)
45. Cip1/WAF1 in keratinocyte differentiation. J Biol Chem 1997; 272:1308-14.
46. Nakano K, Mizuno T, Sowa Y, Orita T, Yoshino T, Okuyama Y, et al. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J Biol Chem 1997; 272:22199-206. (Pubitemid 27382850)
47. Billon N, van Grunsven LA, Rudkin BB. The CDK inhibitor p21WAF1/Cip1 is induced through a p300-dependent mechanism during NGF-mediated neuronal differentiation of PC12 cells. Oncogene 1996; 13:2047-54. (Pubitemid 26411554)
48. Deniaud E, Baguet J, Chalard R, Blanquier B, Brinza L, Meunier J, et al. Overexpression of transcription factor Sp1 leads to gene expression perturbations and cell cycle inhibition. PLoS One 2009; 4:7035.
49. Gervais JL, Seth P, Zhang H. Cleavage of CDK inhibitor p21(Cip1/Waf1) by caspases is an early event during DNA damage-induced apoptosis. J Biol Chem 1998; 273:19207-12. (Pubitemid 28366319)
50. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R. Ceramide synthase mediates daunorubicin- induced apoptosis: an alternative mechanism for generating death signals. Cell 1995; 82:405-14.
51. Lacour S, Hammann A, Grazide S, Lagadic-Gossmann D, Athias A, Sergent O, et al. Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells. Cancer Res 2004; 64:3593-8. (Pubitemid 38657937)
52. Liu YY, Yu JY, Yin D, Patwardhan GA, Gupta V, Hirabayashi Y, et al. A role for ceramide in driving cancer cell resistance to doxorubicin. Faseb J 2008; 22:2541-51. (Pubitemid 351948671)
53. Blagosklonny MV, Robey R, Bates S, Fojo T. Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule- active drugs. J Clin Invest 2000; 105:533-9. (Pubitemid 30127254)
54. Carbonaro M, O'Brate A, Giannakakou P. Microtubule disruption targets HIF-1alpha mRNA to cytoplasmic P-bodies for translational repression. J Cell Biol 2011; 192:83-99.
55. Levine B, Yuan J. Autophagy in cell death: an innocent convict? J Clin Invest 2005; 115:2679-88.
56. Tiwari M, Bajpai VK, Sahasrabuddhe AA, Kumar A, Sinha RA, Behari S, Godbole MM. Inhibition of N-(4-hydroxyphenyl)retinamide-induced autophagy at a lower dose enhances cell death in malignant glioma cells. Carcinogenesis 2008; 29:600-9. (Pubitemid 351404878)
57. Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 2007; 117:326-36. (Pubitemid 46203961)
58. Schumm K, Rocha S, Caamano J, Perkins ND. Regulation of p53 tumour suppressor target gene expression by the p52 NFkappaB subunit. EMBO J 2006; 25:4820-32. (Pubitemid 44607027)
59. Rocha S, Campbell KJ, Perkins ND. p53- and Mdm2- independent repression of NFkappaB transactivation by the ARF tumor suppressor. Mol Cell 2003; 12:15-25. (Pubitemid 36945034)
60. Kenneth NS, Mudie S, van Uden P, Rocha S. SWI/SNF regulates the cellular response to hypoxia. J Biol Chem 2009; 284:4123-31.
61. Culver C, Sundqvist A, Mudie S, Melvin A, Xirodimas D, Rocha S. Mechanism of Hypoxia-Induced NF{kappa}B. Mol Cell Biol 2010; 30:4901-21.